S.RogersP
Michelle Seguin, MD Medical Reviewer Michelle Seguin, MD, is a board-certified family medicine, lifestyle medicine, and certified functional medicine physician (IFMCP)
Page last checked: April 2026
Non-semaglutide GLP-1 medications from Henry Meds Henry offers two other GLP-1 RAs in addition to semaglutide: Tirzepatide: the active ingredient in Mounjaro and Zepbound Liraglutide: the active ingredient in Saxenda and Victoza Of the three drugs, tirzepatide has shown the highest weight loss rates in studies, with one study showing nearly 18% of body weight lost after 72 weeks
No human cases reported for either peptide
The NAC and placebo arms were stratified according to clinical parameters listed in Table 1A, and did not differ between groups, except for maternal pre-gravid BMI, which was slightly higher in the NAC arm in severe IPTB cases (Supplementary Table S2)